BackgroundThe epidermal growth factor receptor (EGFR) p. Thr790Met (T790M) mutation was discovered as a resistance mechanism in patients with lung cancer treated with first- and second-generation tyrosine kinase inhibitors. Further studies revealed the EGFR T790M mutation in treatment-naive non-small cell lung carcinoma (NSCLC) and as a rare germline mutation strongly associated with ... https://www.stehlenautomotivers.shop/product-category/headlights/